Cameron J, Mahanonda N, Aroney C, Hayes J, McEniery P, Gardner M, Bett N
Cardiology Unit, Prince Charles Hospital, Brisbane, Queensland, Australia.
Am J Cardiol. 1994 Sep 15;74(6):544-9. doi: 10.1016/0002-9149(94)90741-2.
Percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) are both used widely for angina but information about their comparative efficacy is limited. This study compared the outcome of 358 consecutive patients undergoing initial revascularization for significant narrowing of the left anterior descending artery (LAD) by PTCA (n = 254) or CABG (n = 104) from 1987 to 1989. PTCA was successful in 93% but complicated by urgent CABG in 3%. A left internal mammary graft was used in 88% of those having elective CABG. There was 1 perioperative death. Follow-up data were obtained after a median interval of 5.5 years (maximum 7.1). Rates for freedom from death (97% PTCA vs 93% CABG, p = 0.06) were similar, but CABG patients had greater rates for freedom from chest pain recurrence (74% CABG vs 48% PTCA, p < 0.0001), myocardial infarction (98% vs 92%, p = 0.04), and from need for further revascularization (99% vs 67%, p < 0.0001). Both groups achieved similar status, with 81% of PTCA and 90% of CABG patients having angina no worse than functional class I. Quality-of-life index was high for both groups (0.983 +/- 0.034/1.000 vs 0.987 +/- 0.032/1.000, p = 0.3). Both PTCA and CABG result in excellent survival, functional ability, and quality of life, but patients undergoing PTCA require more procedures to achieve this.
经皮腔内冠状动脉成形术(PTCA)和冠状动脉旁路移植术(CABG)都广泛用于治疗心绞痛,但关于它们相对疗效的信息有限。本研究比较了1987年至1989年间358例因左前降支(LAD)严重狭窄而首次接受血运重建的连续患者的治疗结果,其中接受PTCA治疗的有254例,接受CABG治疗的有104例。PTCA成功率为93%,但有3%的患者因紧急情况转为CABG。接受择期CABG的患者中有88%使用了左乳内动脉移植。围手术期死亡1例。随访数据的中位间隔时间为5.5年(最长7.1年)。两组的无死亡生存率相似(PTCA组为97%,CABG组为93%,p = 0.06),但CABG患者胸痛复发率更低(CABG组为74%,PTCA组为48%,p < 0.0001),心肌梗死发生率更低(98% 对 92%,p = 0.04),再次血运重建需求率更低(99% 对 67%,p < 0.0001)。两组患者的功能状态相似,PTCA组81%的患者和CABG组90%的患者心绞痛程度不超过I级。两组患者的生活质量指数都较高(0.983±0.034/1.000 对 0.987±0.032/1.000,p = 0.3)。PTCA和CABG都能带来良好的生存率、功能能力和生活质量,但接受PTCA治疗的患者需要更多的手术才能达到这一效果。